远距基因组学市场－全球产业规模、份额、趋势、机会和预测，按服务、专业领域、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球远距基因体学市场规模为3.8881亿美元，预计到2030年将以8.01%的复合年增长率成长至6.1734亿美元。全球远距基因组学市场涵盖透过整合远距医疗和基因组分析，远端提供基因检测、咨询和解读服务。该市场的成长主要得益于电信基础设施的不断进步，这些进步促进了无缝的远距会诊和高效的资料传输。此外，全球慢性病发病率的上升，需要透过基因资讯进行更及时的早期检测和风险评估，这极大地推动了对远距基因组学解决方案的需求。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球远距基因体学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按服务分类（按需存取、基因评估、检测订购、专家后续服务）
  • 按专业领域（癌症遗传学、心血管遗传学、主动遗传学、生殖遗传学、其他）
  • 按最终用户划分（患者及其家属、医疗专业人员、医疗和製药公司、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美远距基因体学市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲远距基因体学市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区远距基因体学市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲远程基因组学市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲远程基因体学市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球远距基因体学市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Genome Medical, Inc.
• FDNA, Inc.
• Illumina, Inc.
• Informed Medical Decisions, Inc
• Invitae Corporation
• Pacific Radiopharmacy, Ltd.
• NTP Radioisotopes SOC Ltd.
• Lantheus Medical Imaging, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Tele-genomics Market, valued at USD 388.81 Million in 2024, is projected to experience a CAGR of 8.01% to reach USD 617.34 Million by 2030. The Global Tele-genomics Market encompasses the delivery of genetic testing, counseling, and interpretation services remotely through the integration of telemedicine and genomic analysis. This market's expansion is primarily driven by continuous advancements in telecommunication infrastructure, which facilitate seamless remote consultations and efficient data transmission. Furthermore, the rising global incidence of chronic diseases, requiring enhanced early detection and risk assessment through genetic insights, significantly fuels the demand for tele-genomics solutions.

Key Market Drivers

The increasing prevalence of chronic and genetic diseases constitutes a significant driver for the global tele-genomics market, necessitating more accessible and efficient diagnostic and counseling services. Conditions like heart disease, cancer, and diabetes, often with genetic predispositions, drive demand for early detection, risk assessment, and personalized treatment. According to the Centers for Disease Control and Prevention, in February 2024, an estimated 129 million people in the United States have at least one major chronic disease, with 42 percent affected by two or more, highlighting a substantial patient population poised for proactive genetic screening and personalized management. Tele-genomics directly addresses geographical and logistical barriers to specialized genetic services, enabling remote patient engagement vital for managing these widespread health challenges.

Key Market Challenges

The inherent complexity of data privacy concerns and the fragmented regulatory landscape across various jurisdictions represent a substantial impediment to the growth of the Global Tele-genomics Market. The highly sensitive nature of genomic information necessitates robust privacy frameworks. However, the absence of harmonized international and even intra-national regulations creates significant challenges for the secure and interoperable exchange of this critical data. This regulatory divergence complicates cross-border service delivery and hinders the establishment of standardized data sharing protocols, which are essential for large-scale genomic research and clinical application.

Key Market Trends

Two significant trends driving the global tele-genomics market are the increasing adoption of AI-powered genomic interpretation for remote consultations and the enhanced interoperability and data standardization for remote genomic platforms. Artificial intelligence is transforming the analysis of complex genomic data, making remote consultations more efficient and precise. This is evident as nearly 30% of the funding poured into healthcare startups in 2024 went to companies leveraging artificial intelligence, according to Silicon Valley Bank. Such investments underscore the growing recognition of AI's capability to process vast datasets and extract meaningful insights. AI-powered genomics has enabled precision medicine with 17.6% higher diagnostic accuracy in breast cancer detection, as reported by Forbes in September 2025. This directly translates into improved diagnostic services deliverable through tele-genomics.

Key Market Players

• Genome Medical, Inc.
• FDNA, Inc.
• Illumina, Inc.
• Informed Medical Decisions, Inc
• Invitae Corporation
• Pacific Radiopharmacy, Ltd.
• NTP Radioisotopes SOC Ltd.
• Lantheus Medical Imaging, Inc.

Report Scope:

In this report, the Global Tele-genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tele-genomics Market, By Services:

• On-Demand Access
• Genetic Assessment
• Test Ordering
• Expert Follow-Up

Tele-genomics Market, By Specialties:

• Cancer Genetics
• Cardio Genetics
• Proactive Genetics
• Reproductive Genetics
• Others

Tele-genomics Market, By End User:

• Patients & Their Families
• Health Professionals
• Health & Pharma Companies
• Others

Tele-genomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Tele-genomics Market.

Available Customizations:

Global Tele-genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tele-genomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Services (On-Demand Access, Genetic Assessment, Test Ordering, Expert Follow-Up)
  • 5.2.2. By Specialties (Cancer Genetics, Cardio Genetics, Proactive Genetics, Reproductive Genetics, Others)
  • 5.2.3. By End User (Patients & Their Families, Health Professionals, Health & Pharma Companies, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Tele-genomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Services
  • 6.2.2. By Specialties
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tele-genomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Services
      • 6.3.1.2.2. By Specialties
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Tele-genomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Services
      • 6.3.2.2.2. By Specialties
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Tele-genomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Services
      • 6.3.3.2.2. By Specialties
      • 6.3.3.2.3. By End User

7. Europe Tele-genomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Services
  • 7.2.2. By Specialties
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Tele-genomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Services
      • 7.3.1.2.2. By Specialties
      • 7.3.1.2.3. By End User
  • 7.3.2. France Tele-genomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Services
      • 7.3.2.2.2. By Specialties
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Tele-genomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Services
      • 7.3.3.2.2. By Specialties
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Tele-genomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Services
      • 7.3.4.2.2. By Specialties
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Tele-genomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Services
      • 7.3.5.2.2. By Specialties
      • 7.3.5.2.3. By End User

8. Asia Pacific Tele-genomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Services
  • 8.2.2. By Specialties
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Tele-genomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Services
      • 8.3.1.2.2. By Specialties
      • 8.3.1.2.3. By End User
  • 8.3.2. India Tele-genomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Services
      • 8.3.2.2.2. By Specialties
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Tele-genomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Services
      • 8.3.3.2.2. By Specialties
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Tele-genomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Services
      • 8.3.4.2.2. By Specialties
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Tele-genomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Services
      • 8.3.5.2.2. By Specialties
      • 8.3.5.2.3. By End User

9. Middle East & Africa Tele-genomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Services
  • 9.2.2. By Specialties
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Tele-genomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Services
      • 9.3.1.2.2. By Specialties
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Tele-genomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Services
      • 9.3.2.2.2. By Specialties
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Tele-genomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Services
      • 9.3.3.2.2. By Specialties
      • 9.3.3.2.3. By End User

10. South America Tele-genomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Services
  • 10.2.2. By Specialties
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Tele-genomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Services
      • 10.3.1.2.2. By Specialties
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Tele-genomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Services
      • 10.3.2.2.2. By Specialties
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Tele-genomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Services
      • 10.3.3.2.2. By Specialties
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Tele-genomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Genome Medical, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. FDNA, Inc.
• 15.3. Illumina, Inc.
• 15.4. Informed Medical Decisions, Inc
• 15.5. Invitae Corporation
• 15.6. Pacific Radiopharmacy, Ltd.
• 15.7. NTP Radioisotopes SOC Ltd.
• 15.8. Lantheus Medical Imaging, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer